Comment on

• Accelerated radiation therapy in non-small cell lung cancer.

  Baumann M. Baumann M. Radiother Oncol. 1999 Aug;52(2):97-9. doi: 10.1016/s0167-8140(99)00111-5. Radiother Oncol. 1999. PMID: 10577694 No abstract available.
• A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial.

  Ball D, Bishop J, Smith J, O'Brien P, Davis S, Ryan G, Olver I, Toner G, Walker Q, Joseph D. Ball D, et al. Radiother Oncol. 1999 Aug;52(2):129-36. doi: 10.1016/s0167-8140(99)00093-6. Radiother Oncol. 1999. PMID: 10577698 Clinical Trial.
• Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee.

  Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Palmar M. Saunders M, et al. Radiother Oncol. 1999 Aug;52(2):137-48. doi: 10.1016/s0167-8140(99)00087-0. Radiother Oncol. 1999. PMID: 10577699 Clinical Trial.